In contrast, activation of ALX/FPR2 signaling has demonstrated therapeutic benefits such as accelerating the resolution of lung injury,30 enhancing alveolar fluid clearance in acute respiratory distress syndrome models,31 and even preventing pulmonary fibrosis.32 The gene discussed is FPR2; the disease is pulmonary fibrosis.